Literature DB >> 28402073

Infantile Hemangiomas: An Updated Review on Risk Factors, Pathogenesis, and Treatment.

Chelsey J Forbess Smith1, Sheila Fallon Friedlander2, Monica Guma1, Arthur Kavanaugh1, Christina D Chambers3,4.   

Abstract

Infantile hemangiomas (IHs) are the most common vascular tumors in infants, appearing in early infancy and ultimately regressing with time. Clinical presentation may vary, with a minority of lesions causing impairment of vital function (e.g., respiratory or visual obstruction), permanent scarring, and/or disfigurement. The pathogenesis of IH is complex and poorly understood. Risk factors implicated in their development include preterm birth and placental anomalies. IH presents a myriad of clinical challenges, including correct diagnosis and whether or not to pursue treatment. This article is a review of the current literature regarding pathogenesis, clinical presentation, treatment, and prognosis of IH. Birth Defects Research 109:809-815, 2017.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  beta blockade; glucose transporter-1 (GLUT-1); hemangioma; hypoxia; pregnancy; vascular endothelial growth factor (VEGF)

Mesh:

Year:  2017        PMID: 28402073      PMCID: PMC5839165          DOI: 10.1002/bdr2.1023

Source DB:  PubMed          Journal:  Birth Defects Res            Impact factor:   2.344


  48 in total

1.  SACRAL syndrome: spinal dysraphism, anogenital, cutaneous, renal and urologic anomalies, associated with an angioma of lumbosacral localization.

Authors:  Annelies Stockman; F Boralevi; Alain Taïeb; Christine Léauté-Labrèze
Journal:  Dermatology       Date:  2007       Impact factor: 5.366

2.  Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation.

Authors:  M L Bennett; A B Fleischer; S L Chamlin; I J Frieden
Journal:  Arch Dermatol       Date:  2001-09

3.  A prospective study of PHACE syndrome in infantile hemangiomas: demographic features, clinical findings, and complications.

Authors:  D W Metry; A N Haggstrom; B A Drolet; E Baselga; S Chamlin; M Garzon; K Horii; A Lucky; A J Mancini; B Newell; A Nopper; G Heyer; I J Frieden
Journal:  Am J Med Genet A       Date:  2006-05-01       Impact factor: 2.802

Review 4.  Approach to haemangiomatosis causing congestive heart failure.

Authors:  Roie Tal; Moshe Dotan; Avraham Lorber
Journal:  Acta Paediatr       Date:  2016-03-06       Impact factor: 2.299

5.  GLUT-1: an extra diagnostic tool to differentiate between haemangiomas and vascular malformations.

Authors:  J Leon-Villapalos; K Wolfe; L Kangesu
Journal:  Br J Plast Surg       Date:  2005-04

6.  A randomized controlled trial of propranolol for infantile hemangiomas.

Authors:  Marcia Hogeling; Susan Adams; Orli Wargon
Journal:  Pediatrics       Date:  2011-07-25       Impact factor: 7.124

7.  A unique microvascular phenotype shared by juvenile hemangiomas and human placenta.

Authors:  P E North; M Waner; A Mizeracki; R E Mrak; R Nicholas; J Kincannon; J Y Suen; M C Mihm
Journal:  Arch Dermatol       Date:  2001-05

Review 8.  Periocular hemangiomas: what every physician should know.

Authors:  Emily J Ceisler; Laura Santos; Francine Blei
Journal:  Pediatr Dermatol       Date:  2004 Jan-Feb       Impact factor: 1.588

Review 9.  Biology of infantile hemangioma.

Authors:  Tinte Itinteang; Aaron H J Withers; Paul F Davis; Swee T Tan
Journal:  Front Surg       Date:  2014-09-25

10.  Human placental renin-angiotensin system in normotensive and pre-eclamptic pregnancies at high altitude and after acute hypoxia-reoxygenation insult.

Authors:  Lesia O Kurlak; Hiten D Mistry; Tereza Cindrova-Davies; Graham J Burton; Fiona Broughton Pipkin
Journal:  J Physiol       Date:  2016-01-19       Impact factor: 5.182

View more
  22 in total

Review 1.  Vascular anomaly imaging mimics and differential diagnoses.

Authors:  Mark D Mamlouk; Christina Danial; William P McCullough
Journal:  Pediatr Radiol       Date:  2019-05-31

2.  Approach to evaluating pregnancy safety of anti-rheumatic medications in the OTIS MotherToBaby pregnancy studies: what have we learned?

Authors:  Christina Chambers; Diana L Johnson; Elizabeth Kiernan
Journal:  Rheumatology (Oxford)       Date:  2018-07-01       Impact factor: 7.580

Review 3.  [Benign skin neoplasms in children].

Authors:  Carmen Maria Salavastru; Alexandra-Irina Butacu; Klaus Fritz; Seher Eren; George-Sorin Tiplica
Journal:  Hautarzt       Date:  2022-01-14       Impact factor: 0.751

4.  ALKBH5 promotes the progression of infantile hemangioma through regulating the NEAT1/miR-378b/FOSL1 axis.

Authors:  Kun Peng; Ren-Peng Xia; Fan Zhao; Yong Xiao; Ti-Dong Ma; Ming Li; Yong Feng; Chong-Gao Zhou
Journal:  Mol Cell Biochem       Date:  2022-02-18       Impact factor: 3.396

5.  Modulation of LIN28B/Let-7 Signaling by Propranolol Contributes to Infantile Hemangioma Involution.

Authors:  Ezinne Francess Mong; Kemal Marc Akat; John Canfield; John Lockhart; Jeffrey VanWye; Andrew Matar; John C M Tsibris; June K Wu; Thomas Tuschl; Hana Totary-Jain
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-05-03       Impact factor: 8.311

6.  Risk of infantile hemangiomas in the offspring of women with autoimmune disease and the pathogenic implications of these lesions.

Authors:  Chelsey J F Smith; Kenneth L Jones; Diana L Johnson; Gretchen Bandoli; Loan K Robinson; Arthur Kavanaugh; Christina D Chambers
Journal:  Am J Med Genet A       Date:  2018-01-17       Impact factor: 2.802

Review 7.  [The most common benign cutaneous neoplasms of vascular, muscular, and adipose tissue and their treatment].

Authors:  Alexandra-Irina Butacu; Iulia-Elena Negulet; Emanuela-Domnica Boieriu; Ioana-Simona Dinu; Andrew Mihalache; Bogdan Mastalier; Carmen Maria Salavastru; Klaus Fritz; George-Sorin Tiplica
Journal:  Hautarzt       Date:  2022-01-18       Impact factor: 0.751

8.  Identification of novel potential biomarkers in infantile hemangioma via weighted gene co-expression network analysis.

Authors:  Bin Xie; Xiongming Zhou; Jiaxuan Qiu
Journal:  BMC Pediatr       Date:  2022-05-01       Impact factor: 2.567

Review 9.  Current perspectives on the optimal management of infantile hemangioma.

Authors:  Peter Grzesik; June K Wu
Journal:  Pediatric Health Med Ther       Date:  2017-12-06

10.  Competitive endogenous RNA networks: integrated analysis of non-coding RNA and mRNA expression profiles in infantile hemangioma.

Authors:  Jun Li; Qian Li; Ling Chen; Yanli Gao; Bei Zhou; Jingyun Li
Journal:  Oncotarget       Date:  2018-01-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.